Advancements in Pharmacovigilance

Pharmacovigilance has become more data-driven, incorporating advanced analytics and real-world data (RWD) to monitor the safety of medications post-market. The integration of AI and machine learning helps identify patterns in adverse drug reactions (ADRs), improving the speed and accuracy of safety signal detection. Recent research emphasizes proactive pharmacovigilance, focusing on risk management strategies that assess long-term drug safety, especially for biologics and personalized medicines. Enhanced reporting systems and global data-sharing initiatives are improving the ability to detect safety concerns and ensure regulatory compliance, ultimately enhancing patient safety.

    Related Conference of Advancements in Pharmacovigilance

    July 27-28, 2026

    19th World Drug Delivery Summit

    Paris, France
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 14-15, 2026

    6th International Conference on Pharmaceutical Chemistry

    Paris, France
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2026

    5th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 26-27, 2026

    5th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    December 14-15, 2026

    5th Global Summit on Pharmaceutical Research

    Paris, France
    January 26-27, 2027

    22nd Annual Meet on Pharmaceutical Sciences

    Paris, France
    April 27-28, 2027

    10th European Biopharma Congress

    Paris, France

    Advancements in Pharmacovigilance Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in